Japan approves Novartis’ oral MS drug Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Japan approves Novartis’ oral MS drug Gilenya

Post by MSUK »

Image

Japanese regulatory authorities have approved Novartis’ once-daily multiple sclerosis (MS) drug Gilenya.

The Gilenya sanction covers use of the drug for preventing relapse and delaying progression of physical disability in adult MS patients.

The only other drug licensed in Japan for preventing relapse of MS patients is interferon beta. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Gilenya”